Hemodialysis Market to Witness a Pronounce Growth by 2025

Document technical information

Format docx
Size 47.3 kB
First found Dec 18, 2017

Document content analysis

Category Also themed
not defined
no text concepts found





Hemodialysis Market - Global Industry Analysis, Size, Share,
Growth, Trends and Forecast 2017 - 2025
Hemodialysis is a process that uses artificial membrane to remove waste,
such as urea, from the blood, restore proper balance of electrolytes in the
blood, and eliminate extra fluid from the body. When kidney function goes
below 10% to 15%, it is no longer able to filter blood. This causes toxins to
build up in the body along with excess fluid. Hemodialysis is used to remove
these toxins. It is an effective treatment for those with end stage renal disease.
There are different types of hemodialysis. In-center hemodialysis is
performed in hospitals or dialysis centers. Home hemodialysis is done at
home three days a week in presence of a technician. Daily home
hemodialysis is done at home five to seven days a week. Nocturnal home
hemodialysis is done overnight in six to eight hours.
According to the National Kidney Foundation, 10% of the global population
is affected by chronic kidney disease (CKD). Over 2 million people currently
receive treatment with dialysis or a kidney transplant. Of these 2 million
people receive treatment for kidney failure, the majority are treated in only
five countries: the U.S., Japan, Germany, Brazil, and Italy. These five
countries represent only 12% of the world’s population. Only 20% are treated
in about 100 developing countries which make up over 50% of the world’s
population. According to 2010 Global Burden of Disease study, chronic
kidney disease was ranked 27th in the list of causes of total number of deaths
worldwide in 1990, but rose to 18th in 2010. According to the National
Institute of Diabetes and Digestive and Kidney Diseases Health Information
Center, over 661,000 people in the U.S. have kidney failure. Of these,
468,000 individuals are on dialysis, and roughly 193,000 live with a
functioning kidney transplant. In 2013, 88.2% of patients began renal
replacement therapy with hemodialysis, 9.0% started with peritoneal dialysis,
and 2.6% received preemptive kidney transplant. As of 2013, 63.7% of all
ESRD patients were receiving hemodialysis therapy, 6.8% were being treated
with peritoneal dialysis, and 29.2% had a functioning kidney transplant.
Browse Full Research Report:
The hemodialysis market can be segmented into hemodialysis products,
consumables, and hemodialysis services. Increasing incidence of kidney
failure and chronic renal dysfunction is expected to propel the hemodialysis
market during the forecast period. Additionally, growing awareness about
hemodialysis devices and services is anticipated to generate high demand for
hemodialysis treatment globally during the forecast period.
Based on product type, the hemodialysis market has been segmented into
dialyzers and hemodialysis machines. Based on services, the hemodialysis
market has been segmented into in-center hemodialysis services and home
hemodialysis services.
In terms of region, the global hemodialysis market has been segmented into
North America, Europe, Asia Pacific, Latin America, and Middle East &
Africa. The U.S. is considered the world’s largest market for hemodialysis
products, followed by Europe. Japan has become the third largest
hemodialysis market in Asia. Collaboration between product manufacturers
and service providers is augmenting the hemodialysis market. Fresenius
Medical Care AG & Co. KGaA announced the opening of eight new centers
in collaboration with John Hopkins Hospital in 2017. These centers would be
located in Baltimore, the U.S., to meet the rising demand in the region.
The focus of manufacturers is on the shift from the use of no-tunneled
dialysis catheters to tunneled cuffed dialysis catheters in the recent past for
vascular access. These catheters are suggested for short and intermediate use.
Major players in the hemodialysis market are Baxter International, B. Braun
Medical Ltd., DaVita, Inc., Fresenius Medical Care AG & Co. KGaA, Toray
Industries, Inc., Nikkiso Co. Ltd., JMS Co. Ltd., and Gambro, among others.
Browse Full Press Release:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers. TMR’s
experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency Market
Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

Report this document